On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value.

Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...

The Department of Justice on Tuesday sued to prevent UnitedHealth Group from buying Amedisys, a deal the government said ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

Biotech startup Orna Therapeutics has cut more jobs in its second round of layoffs in the last year, STAT has learned. Orna ...

The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic ...

Narcotics Anonymous and Salvation Army are often hostile to use of the addiction medications buprenorphine and methadone.

For AbbVie, the failure of a high-profile schizophrenia drug hardly marks its last chance to invest in neuroscience. But the ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...

No FDA-approved rapid tests exist that specifically test for H5N1, and the first near-point-of-care test for mpox was ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...